EN | RU
EN | RU

Help Support

Back

Safety and efficacy of dimethylfumarate to treat psoriasis in elderly people

Safety and efficacy of dimethylfumarate to treat psoriasis in elderly people Safety and efficacy of dimethylfumarate to treat psoriasis in elderly people
Safety and efficacy of dimethylfumarate to treat psoriasis in elderly people Safety and efficacy of dimethylfumarate to treat psoriasis in elderly people

A study was carried out to investigate dimethylfumarate use for the management of elderly people suffering from psoriasis.

See All

Key take away

For the management of elderly people with moderate-to-severe psoriasis, dimethylfumarate seems to be an effective agent with good tolerability.

Background

A study was carried out to investigate dimethylfumarate use for the management of elderly people suffering from psoriasis.

Method

This retrospective multicentric study incorporated 81 elderly (>65 years) psoriatic patients (48 males and 33 females) treated with dimethylfumarate up to 24 weeks. With the aid of Psoriasis Area and Severity Index (PASI) score, dimethylfumarate's efficacy was assessed up to 24 weeks. Drug maintenance and safety were also examined.

Result

The PASI score at week 0 ranged from 3,7-24 (mean ± standard deviation, 9,8 ± 4,1), that altered after dimethylfumarate administration at week 16 and 24, as illustrated in Table 1:


Among 81 participants, 59 (72,8%) adverse events were witnessed during the observation period. Flushes (n = 10, 12,3%) and gastrointestinal complaints (n = 24, 29,6%) were the most commonly noted adverse events. Lymphocytopenia (n = 10, 12,35%) was oftenly noted.

Conclusion

Dimethylfumarate may be a first-line systemic therapy choice for managing elderly psoriasis since it led to improvement of disease severity in the majority of the patients. However, the long-term safety data should be closely monitored, in particular, lymphocytopenia. 

Source:

The Journal of Dermatological Treatment

Article:

Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study

Authors:

Federica Ricceri et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: